Global Infectious Disease Therapeutics Market Size & Outlook

The infectious disease therapeutics industry worldwide is expected to reach a projected revenue of US$ 115.2 million by 2030. A compound annual growth rate of 7.1% is expected of the worldwide infectious disease therapeutics industry from 2024 to 2030.
Revenue, 2023 (US$M)
$71.5
Forecast, 2030 (US$M)
$115.2
CAGR, 2024 - 2030
7.1%
Report Coverage
Worldwide

Global infectious disease therapeutics market, 2018-2030 (US$M)

Global infectious disease therapeutics market highlights

  • The global infectious disease therapeutics market generated a revenue of USD 71.5 million in 2023 and is expected to reach USD 115.2 million by 2030.
  • The market is expected to grow at a CAGR (2024 - 2030) of 7.1% by 2030.
  • In terms of segment, hiv accounted for a revenue of USD 71.5 million in 2023.
  • HIV is the most lucrative application segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2023.

Global data book summary

Market revenue in 2023USD 71.5 million
Market revenue in 2030USD 115.2 million
Growth rate7.1% (CAGR from 2023 to 2030)
Largest segmentHiv
Fastest growing segmentHIV
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationHIV

Other key industry trends

  • In terms of revenue, the North America accounted for 39.7% of the global infectious disease therapeutics market in 2023.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Infectious Disease Therapeutics Market Scope

Infectious disease therapeutics market segmentation & scope
HIV
Hepatitis
Influenza
TB
Malaria
HPV
End Use
Hospital
Clinics
Others
Countries
U.S.
Canada
Argentina
Brazil
Mexico
UK
Germany
Denmark
France
Italy
Spain
Sweden
UAE
South Africa
Saudi Arabia
Kuwait
Thailand
India
China
Japan
South Korea

Infectious Disease Therapeutics Market Companies

Name Profile # Employees HQ Website

Global infectious disease therapeutics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious disease therapeutics market will help companies and investors design strategic landscapes.


Hiv was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Global infectious disease therapeutics market based on hiv covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global Infectious Disease Therapeutics Application Outlook (Revenue, USD Million, 2018-2030)
    • HIV
    • Hepatitis
    • Influenza
    • TB
    • Malaria
    • HPV
  • Global Infectious Disease Therapeutics End Use Outlook (Revenue, USD Million, 2018-2030)
    • Hospital
    • Clinics
    • Others

Reasons to subscribe to Global infectious disease therapeutics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global infectious disease therapeutics market databook

  • Our clientele includes a mix of infectious disease therapeutics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global infectious disease therapeutics market , including forecasts for subscribers. This global databook contains high-level insights into Global infectious disease therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global infectious disease therapeutics market size, by regions, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more